Skip to main content

Table 5 Summary of adverse events

From: Effect of sitagliptin on blood glucose control in patients with type 2 diabetes mellitus who are treatment naive or poorly responsive to existing antidiabetic drugs: the JAMP study

Hypoglycemia 3
Hyperglycemia 1
Hematopoietic disorders 3
Cardiovascular disease 8
Respiratory disorders 2
Skin eruption 2
Gastrointestinal disorders 5
Hepatobiliary disorders 7
Renal and urinary disorders 2
Neuropsychiatric disorders 2
Others 20
Total 55